Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5131-5140 of 11789

Edit search filters
  1. Epcoritamab Compared To Observation For Treating B-cell Lymphoma Patients Not In Complete Remission After CD19-directed CAR-T Therapy

    Jacksonville, FL, Rochester, MN

  2. A Study Of BT5528 In Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Letrozole After Tamoxifen in Treating Women With Breast Cancer

    La Crosse, WI

  5. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

    Rochester, MN

  6. A Study To Evaluate Trabectedin With Olaparib In Advanced Unresectable Or Metastatic Sarcoma

    Rochester, MN

  7. Evaluating The Addition Of Adjuvant Chemotherapy To Ovarian Function Suppression Plus Endocrine Therapy In Premenopausal Patients With PN0-1, ER-Positive/HER2-Negative Breast Cancer And An Oncotype Recurrence Score Less Than Or Equal To 25

    Scottsdale/Phoenix, AZ, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  8. (Apex) Bezuclastinib In Patients With Advanced Systemic Mastocytosis

    Scottsdale/Phoenix, AZ

  9. A Study of the Role of Elevated Free Fatty Acids in Blood Plasma for the Regulation of Muscle Protein Manufacture

  10. Epigenetics and the Origin of Muscle Insulin Resistance in Humans

.

Mayo Clinic Footer